{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T23:42:35Z","timestamp":1774136555137,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T00:00:00Z","timestamp":1745625600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004160","name":"Mazandaran University of Medical Sciences","doi-asserted-by":"publisher","award":["18324"],"award-info":[{"award-number":["18324"]}],"id":[{"id":"10.13039\/501100004160","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s10067-025-07461-5","type":"journal-article","created":{"date-parts":[[2025,4,26]],"date-time":"2025-04-26T15:11:14Z","timestamp":1745680274000},"page":"2201-2212","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["SLAM receptors regulate immune checkpoints via SAP and EAT- 2 in rheumatoid arthritis: association with disease activity"],"prefix":"10.1007","volume":"44","author":[{"given":"Mohammad","family":"Malekan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armin","family":"Dozandeh-Jouybari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Najmeh","family":"Sadeghian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Soltanshahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Azadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abolghasem","family":"Ajami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Asgarian-Omran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8813-6046","authenticated-orcid":false,"given":"Saeid","family":"Taghiloo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,26]]},"reference":[{"issue":"1","key":"7461_CR1","doi-asserted-by":"publisher","first-page":"4394","DOI":"10.1038\/s41467-023-40113-3","volume":"14","author":"WD Luo","year":"2023","unstructured":"Luo WD, Wang YP, Lv J, Liu Y, Qu YQ, Xu XF et al (2023) Age-related self-DNA accumulation may accelerate arthritis in rats and in human rheumatoid arthritis. Nat Commun 14(1):4394. https:\/\/doi.org\/10.1038\/s41467-023-40113-3","journal-title":"Nat Commun"},{"issue":"1","key":"7461_CR2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13018-021-02901-9","volume":"17","author":"G Xia","year":"2022","unstructured":"Xia G, Li Y, Pan W, Qian C, Ma L, Zhou J et al (2022) SLAMF6 is associated with the susceptibility and severity of rheumatoid arthritis in the Chinese population. J Orthop Surg Res 17(1):13. https:\/\/doi.org\/10.1186\/s13018-021-02901-9","journal-title":"J Orthop Surg Res"},{"issue":"7","key":"7461_CR3","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.3390\/ijms23073529","volume":"23","author":"G Baldanzi","year":"2022","unstructured":"Baldanzi G (2022) Immune checkpoint receptors signaling in T Cells. Int J Mol Sci 23(7):3529. https:\/\/doi.org\/10.3390\/ijms23073529","journal-title":"Int J Mol Sci"},{"issue":"10","key":"7461_CR4","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2017-211216","volume":"76","author":"R Belkhir","year":"2017","unstructured":"Belkhir R, Burel SL, Dunogeant L, Marabelle A, Hollebecque A, Besse B et al (2017) Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment. Ann Rheum Dis 76(10):1747\u20131750. https:\/\/doi.org\/10.1136\/annrheumdis-2017-211216","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"7461_CR5","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1586\/1744666x.2016.1133295","volume":"12","author":"M Cutolo","year":"2016","unstructured":"Cutolo M, Sulli A, Paolino S, Pizzorni C (2016) CTLA-4 blockade in the treatment of rheumatoid arthritis: an update. Expert Rev Clin Immunol 12(4):417\u2013425. https:\/\/doi.org\/10.1586\/1744666x.2016.1133295","journal-title":"Expert Rev Clin Immunol"},{"issue":"1","key":"7461_CR6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.cellimm.2014.05.006","volume":"290","author":"S Dai","year":"2014","unstructured":"Dai S, Jia R, Zhang X, Fang Q, Huang L (2014) The PD-1\/PD-Ls pathway and autoimmune diseases. Cell Immunol 290(1):72\u201379. https:\/\/doi.org\/10.1016\/j.cellimm.2014.05.006","journal-title":"Cell Immunol"},{"issue":"8","key":"7461_CR7","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1007\/s10067-018-4076-4","volume":"37","author":"Z Koohini","year":"2018","unstructured":"Koohini Z, Hossein-Nataj H, Mobini M, Hosseinian-Amiri A, Rafiei A, Asgarian-Omran H (2018) Analysis of PD-1 and Tim-3 expression on CD4(+) T cells of patients with rheumatoid arthritis; negative association with DAS28. Clin Rheumatol 37(8):2063\u20132071. https:\/\/doi.org\/10.1007\/s10067-018-4076-4","journal-title":"Clin Rheumatol"},{"issue":"6","key":"7461_CR8","doi-asserted-by":"publisher","first-page":"646","DOI":"10.18502\/ijaai.v21i6.11524","volume":"21","author":"M Hemmatzadeh","year":"2022","unstructured":"Hemmatzadeh M, AhangarParvin E, Ghanavatinejad A, Rostami N, Hajaliloo M, Shomali N et al (2022) MicroRNAs Targeting Programmed Cell Death Protein 1 (PD-1) Promote Natural Killer Cell Exhaustion in Rheumatoid Arthritis. Iran J Allergy Asthma Immunol 21(6):646\u201356. https:\/\/doi.org\/10.18502\/ijaai.v21i6.11524","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"4","key":"7461_CR9","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3892\/etm.2022.11579","volume":"24","author":"Q Luo","year":"2022","unstructured":"Luo Q, Fu P, Guo Y, Fu B, Guo Y, Huang Q et al (2022) Increased TIGIT(+)PD-1(+)CXCR5(-)CD4(+)T cells are associated with disease activity in rheumatoid arthritis. Exp Ther Med 24(4):642. https:\/\/doi.org\/10.3892\/etm.2022.11579","journal-title":"Exp Ther Med"},{"issue":"1","key":"7461_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13075-023-03073-z","volume":"25","author":"JM Pedersen","year":"2023","unstructured":"Pedersen JM, Hansen AS, Skej\u00f8 C, Juul-Madsen K, Junker P, H\u00f8rslev-Petersen K et al (2023) Lymphocyte activation gene 3 is increased and affects cytokine production in rheumatoid arthritis. Arthritis Res Ther 25(1):97. https:\/\/doi.org\/10.1186\/s13075-023-03073-z","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"7461_CR11","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1038\/ni.2035","volume":"12","author":"EJ Wherry","year":"2011","unstructured":"Wherry EJ (2011) T cell exhaustion. Nat Immunol 12(6):492\u2013499. https:\/\/doi.org\/10.1038\/ni.2035","journal-title":"Nat Immunol"},{"issue":"2","key":"7461_CR12","doi-asserted-by":"publisher","first-page":"e13245","DOI":"10.1111\/sji.13245","volume":"97","author":"K Pedersen","year":"2023","unstructured":"Pedersen K, Nielsen MA, Juul-Madsen K, Hvid M, Deleuran B, Greisen SR (2023) Galectin-3 interacts with PD-1 and counteracts the PD-1 pathway-driven regulation of T cell and osteoclast activity in Rheumatoid Arthritis. Scand J Immunol 97(2):e13245. https:\/\/doi.org\/10.1111\/sji.13245","journal-title":"Scand J Immunol"},{"key":"7461_CR13","doi-asserted-by":"publisher","first-page":"654839","DOI":"10.3389\/fimmu.2021.654839","volume":"12","author":"Y Gartshteyn","year":"2021","unstructured":"Gartshteyn Y, Askanase AD, Mor A (2021) SLAM associated protein signaling in T Cells: tilting the balance toward autoimmunity. Front Immunol 12:654839. https:\/\/doi.org\/10.3389\/fimmu.2021.654839","journal-title":"Front Immunol"},{"issue":"7","key":"7461_CR14","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.autrev.2018.01.018","volume":"17","author":"MA Dragovich","year":"2018","unstructured":"Dragovich MA, Mor A (2018) The SLAM family receptors: potential therapeutic targets for inflammatory and autoimmune diseases. Autoimmun Rev 17(7):674\u2013682. https:\/\/doi.org\/10.1016\/j.autrev.2018.01.018","journal-title":"Autoimmun Rev"},{"key":"7461_CR15","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.clim.2018.10.011","volume":"204","author":"M Claus","year":"2019","unstructured":"Claus M, Urlaub D, Fasbender F, Watzl C (2019) SLAM family receptors in natural killer cells - Mediators of adhesion, activation and inhibition via cis and trans interactions. Clin Immunol (Orlando, Fla) 204:37\u201342. https:\/\/doi.org\/10.1016\/j.clim.2018.10.011","journal-title":"Clin Immunol (Orlando, Fla)"},{"issue":"9","key":"7461_CR16","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1084\/jem.20040588","volume":"199","author":"A Veillette","year":"2004","unstructured":"Veillette A (2004) SLAM family receptors regulate immunity with and without SAP-related adaptors. J Exp Med 199(9):1175\u20138. https:\/\/doi.org\/10.1084\/jem.20040588","journal-title":"J Exp Med"},{"key":"7461_CR17","doi-asserted-by":"publisher","unstructured":"Lowe K, Kasparian J, Small A, Weedon H, Masle-Farquhar E, Singh M et al. eds. (2024) Characterisation of Signalling Lymphocytic Activation Molecules (SLAM) in patients with early Rheumatoid Arthritis. European Congress of Rheumatology. https:\/\/doi.org\/10.1136\/annrheumdis-2024-eular.620","DOI":"10.1136\/annrheumdis-2024-eular.620"},{"issue":"9","key":"7461_CR18","doi-asserted-by":"publisher","first-page":"743","DOI":"10.3390\/cells13090743","volume":"13","author":"J Perera","year":"2024","unstructured":"Perera J, Delrosso CA, Nerviani A, Pitzalis C (2024) Clinical phenotypes, serological biomarkers, and synovial features defining seropositive and seronegative rheumatoid arthritis: a literature review. Cells 13(9):743. https:\/\/doi.org\/10.3390\/cells13090743","journal-title":"Cells"},{"key":"7461_CR19","doi-asserted-by":"publisher","first-page":"1447213","DOI":"10.3389\/fimmu.2024.1447213","volume":"15","author":"B Li","year":"2024","unstructured":"Li B, Su R, Guo Q, Su R, Gao C, Li X et al (2024) Differential immunological profiles in seronegative versus seropositive rheumatoid arthritis: Th17\/Treg dysregulation and IL-4. Front Immunol 15:1447213. https:\/\/doi.org\/10.3389\/fimmu.2024.1447213","journal-title":"Front Immunol"},{"issue":"3","key":"7461_CR20","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31(3):315\u2013324. https:\/\/doi.org\/10.1002\/art.1780310302","journal-title":"Arthritis Rheum"},{"issue":"10055","key":"7461_CR21","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/s0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB (2016) Rheumatoid arthritis. Lancet (London, England) 388(10055):2023\u20132038. https:\/\/doi.org\/10.1016\/s0140-6736(16)30173-8","journal-title":"Lancet (London, England)"},{"key":"7461_CR22","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3389\/fimmu.2016.00004","volume":"7","author":"BJ van Driel","year":"2016","unstructured":"van Driel BJ, Liao G, Engel P, Terhorst C (2016) Responses to microbial challenges by SLAMF receptors. Front Immunol 7:4. https:\/\/doi.org\/10.3389\/fimmu.2016.00004","journal-title":"Front Immunol"},{"key":"7461_CR23","doi-asserted-by":"publisher","first-page":"1174138","DOI":"10.3389\/fimmu.2023.1174138","volume":"14","author":"P Farhangnia","year":"2023","unstructured":"Farhangnia P, Ghomi SM, Mollazadehghomi S, Nickho H, Akbarpour M, Delbandi AA (2023) SLAM-family receptors come of age as a potential molecular target in cancer immunotherapy. Front Immunol 14:1174138. https:\/\/doi.org\/10.3389\/fimmu.2023.1174138","journal-title":"Front Immunol"},{"issue":"2","key":"7461_CR24","doi-asserted-by":"publisher","first-page":"279","DOI":"10.3390\/cancers13020279","volume":"13","author":"M Ishibashi","year":"2021","unstructured":"Ishibashi M, Morita R, Tamura H (2021) Immune functions of signaling lymphocytic activation molecule family molecules in multiple myeloma. Cancers 13(2):279. https:\/\/doi.org\/10.3390\/cancers13020279","journal-title":"Cancers"},{"issue":"6","key":"7461_CR25","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.4049\/jimmunol.159.6.2986","volume":"159","author":"P Isom\u00e4ki","year":"1997","unstructured":"Isom\u00e4ki P, Aversa G, Cocks BG, Luukkainen R, Saario R, Toivanen P et al (1997) Increased expression of signaling lymphocytic activation molecule in patients with rheumatoid arthritis and its role in the regulation of cytokine production in rheumatoid synovium. J Immunol (Baltimore, Md\u202f: 1950) 159(6):2986\u201393","journal-title":"J Immunol (Baltimore, Md : 1950)"},{"key":"7461_CR26","doi-asserted-by":"publisher","first-page":"961129","DOI":"10.3389\/fimmu.2022.961129","volume":"13","author":"A Li","year":"2022","unstructured":"Li A, Zhang Z, Ru X, Yi Y, Li X, Qian J et al (2022) Identification of SLAMF1 as an immune-related key gene associated with rheumatoid arthritis and verified in mice collagen-induced arthritis model. Front Immunol 13:961129. https:\/\/doi.org\/10.3389\/fimmu.2022.961129","journal-title":"Front Immunol"},{"key":"7461_CR27","doi-asserted-by":"publisher","unstructured":"Lowe K, Kasparian J, Small A, Weedon H, Masle-Farquhar E, Singh M et al (2024) POS1224 Characterisation of signalling lymphocytic activation molecules (SLAM) in patients with early rheumatoid arthritis. BMJ Publishing Group Ltd. https:\/\/doi.org\/10.1136\/annrheumdis-2024-eular.620","DOI":"10.1136\/annrheumdis-2024-eular.620"},{"issue":"68","key":"7461_CR28","doi-asserted-by":"publisher","first-page":"eabf2846","DOI":"10.1126\/sciimmunol.abf2846","volume":"7","author":"DP Simmons","year":"2022","unstructured":"Simmons DP, Nguyen HN, Gomez-Rivas E, Jeong Y, Jonsson AH, Chen AF et al (2022) SLAMF7 engagement superactivates macrophages in acute and chronic inflammation. Sci Immunol 7(68):eabf2846. https:\/\/doi.org\/10.1126\/sciimmunol.abf2846","journal-title":"Sci Immunol"},{"key":"7461_CR29","doi-asserted-by":"publisher","first-page":"1306584","DOI":"10.3389\/fphar.2023.1306584","volume":"14","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Zhao J, Zhou M, Wei K, Jiang P, Xu L et al (2023) Role of signaling lymphocytic activation molecule family of receptors in the pathogenesis of rheumatoid arthritis: insights and application. Front Pharmacol 14:1306584. https:\/\/doi.org\/10.3389\/fphar.2023.1306584","journal-title":"Front Pharmacol"},{"issue":"1","key":"7461_CR30","doi-asserted-by":"publisher","first-page":"228","DOI":"10.4049\/jimmunol.1800847","volume":"202","author":"P O'Connell","year":"2019","unstructured":"O\u2019Connell P, Pepelyayeva Y, Blake MK, Hyslop S, Crawford RB, Rizzo MD et al (2019) SLAMF7 is a critical negative regulator of IFN-\u03b1-Mediated CXCL10 production in chronic HIV infection. J Immunol (Baltimore, Md\u202f: 1950) 202(1):228\u201338. https:\/\/doi.org\/10.4049\/jimmunol.1800847","journal-title":"J Immunol (Baltimore, Md : 1950)"},{"issue":"2","key":"7461_CR31","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.3892\/mmr.2017.8204","volume":"17","author":"Q Luo","year":"2018","unstructured":"Luo Q, Ye J, Zeng L, Luo Z, Deng Z, Li X et al (2018) Elevated expression of PD-1 on T cells correlates with disease activity in rheumatoid arthritis. Mol Med Rep 17(2):3297\u20133305. https:\/\/doi.org\/10.3892\/mmr.2017.8204","journal-title":"Mol Med Rep"},{"key":"7461_CR32","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.imlet.2020.10.005","volume":"228","author":"F Ajam","year":"2020","unstructured":"Ajam F, Aghaei M, Mohammadi S, Samiei H, Behnampour N, Memarian A (2020) PD-1 Expression on CD8+CD28- T cells within inflammatory synovium is associated with Relapse: a cohort of Rheumatoid Arthritis. Immunol Lett 228:76\u201382. https:\/\/doi.org\/10.1016\/j.imlet.2020.10.005","journal-title":"Immunol Lett"},{"issue":"2","key":"7461_CR33","doi-asserted-by":"publisher","first-page":"e0192704","DOI":"10.1371\/journal.pone.0192704","volume":"13","author":"Y Guo","year":"2018","unstructured":"Guo Y, Walsh AM, Canavan M, Wechalekar MD, Cole S, Yin X et al (2018) Immune checkpoint inhibitor PD-1 pathway is down-regulated in synovium at various stages of rheumatoid arthritis disease progression. PLoS One 13(2):e0192704. https:\/\/doi.org\/10.1371\/journal.pone.0192704","journal-title":"PLoS One"},{"issue":"1","key":"7461_CR34","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1007\/s10753-013-9718-8","volume":"37","author":"S Li","year":"2014","unstructured":"Li S, Liao W, Chen M, Shan S, Song Y, Zhang S et al (2014) Expression of programmed death-1 (PD-1) on CD4+ and CD8+ T cells in rheumatoid arthritis. Inflammation 37(1):116\u2013121. https:\/\/doi.org\/10.1007\/s10753-013-9718-8","journal-title":"Inflammation"},{"key":"7461_CR35","doi-asserted-by":"publisher","first-page":"932627","DOI":"10.3389\/fimmu.2022.932627","volume":"13","author":"V Anaparti","year":"2022","unstructured":"Anaparti V, Tanner S, Zhang C, O\u2019Neil L, Smolik I, Meng X et al (2022) Increased frequency of TIGIT+ CD4 T Cell subset in autoantibody-positive first-degree relatives of patients with rheumatoid arthritis. Front Immunol 13:932627. https:\/\/doi.org\/10.3389\/fimmu.2022.932627","journal-title":"Front Immunol"},{"key":"7461_CR36","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.12659\/msm.902454","volume":"23","author":"Q Luo","year":"2017","unstructured":"Luo Q, Deng Z, Xu C, Zeng L, Ye J, Li X et al (2017) Elevated expression of immunoreceptor tyrosine-based inhibitory motif (TIGIT) on T lymphocytes is correlated with disease activity in rheumatoid arthritis. Med Sci Monit: Int Med J Exp Clin Res 23:1232\u201341. https:\/\/doi.org\/10.12659\/msm.902454","journal-title":"Med Sci Monit: Int Med J Exp Clin Res"},{"key":"7461_CR37","doi-asserted-by":"publisher","first-page":"216726","DOI":"10.1016\/j.canlet.2024.216726","volume":"588","author":"M Gao","year":"2024","unstructured":"Gao M, Shi J, Xiao X, Yao Y, Chen X, Wang B et al (2024) PD-1 regulation in immune homeostasis and immunotherapy. Cancer Lett 588:216726. https:\/\/doi.org\/10.1016\/j.canlet.2024.216726","journal-title":"Cancer Lett"},{"issue":"1","key":"7461_CR38","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s12943-024-02023-w","volume":"23","author":"X Lin","year":"2024","unstructured":"Lin X, Kang K, Chen P, Zeng Z, Li G, Xiong W et al (2024) Regulatory mechanisms of PD-1\/PD-L1 in cancers. Mol Cancer 23(1):108. https:\/\/doi.org\/10.1186\/s12943-024-02023-w","journal-title":"Mol Cancer"},{"issue":"31","key":"7461_CR39","doi-asserted-by":"publisher","first-page":"4992","DOI":"10.1038\/s41388-021-01896-1","volume":"40","author":"Y Qiu","year":"2021","unstructured":"Qiu Y, Yang Y, Yang R, Liu C, Hsu JM, Jiang Z et al (2021) Activated T cell-derived exosomal PD-1 attenuates PD-L1-induced immune dysfunction in triple-negative breast cancer. Oncogene 40(31):4992\u20135001. https:\/\/doi.org\/10.1038\/s41388-021-01896-1","journal-title":"Oncogene"},{"key":"7461_CR40","doi-asserted-by":"publisher","unstructured":"Tan CL, Kuchroo JR, Sage PT, Liang D, Francisco LM, Buck J et al (2021) PD-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance. J Exp Med 218(1). https:\/\/doi.org\/10.1084\/jem.20182232","DOI":"10.1084\/jem.20182232"},{"issue":"3","key":"7461_CR41","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/s41584-020-0373-9","volume":"16","author":"BN Cronstein","year":"2020","unstructured":"Cronstein BN, Aune TM (2020) Methotrexate and its mechanisms of action in inflammatory arthritis. Nat Rev Rheumatol 16(3):145\u2013154. https:\/\/doi.org\/10.1038\/s41584-020-0373-9","journal-title":"Nat Rev Rheumatol"},{"issue":"2","key":"7461_CR42","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s12016-010-8243-x","volume":"42","author":"I Ben-Zvi","year":"2012","unstructured":"Ben-Zvi I, Kivity S, Langevitz P, Shoenfeld Y (2012) Hydroxychloroquine: from malaria to autoimmunity. Clin Rev Allergy Immunol 42(2):145\u2013153. https:\/\/doi.org\/10.1007\/s12016-010-8243-x","journal-title":"Clin Rev Allergy Immunol"},{"issue":"3","key":"7461_CR43","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1111\/j.1572-0241.2003.07305.x","volume":"98","author":"O Schr\u00f6der","year":"2003","unstructured":"Schr\u00f6der O, Stein J (2003) Low dose methotrexate in inflammatory bowel disease: current status and future directions. Am J Gastroenterol 98(3):530\u2013537. https:\/\/doi.org\/10.1111\/j.1572-0241.2003.07305.x","journal-title":"Am J Gastroenterol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07461-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-025-07461-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-025-07461-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T13:21:09Z","timestamp":1749129669000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-025-07461-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,26]]},"references-count":43,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["7461"],"URL":"https:\/\/doi.org\/10.1007\/s10067-025-07461-5","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,26]]},"assertion":[{"value":"22 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 April 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was found to be ethically acceptable by the Ethical Committee of Mazandaran University of Medical Sciences (IR.MAZUMS.REC.1402.415).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare that they have no conflict of interests concerning the contents of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}